P3.03-006 Efficiency of Anlotinib as 3rd Line Treatment in Patients with Different EGFR Gene Status, an Exploratory Subgroup Analysis of ALTER0303 Trial

Authors :: Y. Luo
Xiuwen Wang
F. Jin
W. Chen
Y. Cheng
Lifan Zhang
Yizhuo Zhao
Kai Li
Baolan Li
Kejun Nan
Q. Wang
Jing He
Baohui Han
Z. Wang
S. Yuankai
J. Shi
Source :: Journal of Thoracic Oncology. 12:S2275
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
Pulmonary and Respiratory Medicine
Oncology
medicine.medical_specialty
business.industry
Subgroup analysis
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
030220 oncology & carcinogenesis
Internal medicine
Medicine
In patient
Line (text file)
business
Gene

Full Text Access

Tools